Mape Pharmascience Llp Profile
Key Indicators
- Obligation of Contribution ₹ 2.00 Cr
as on 21-01-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 133.50 Cr
as on 21-01-2024
- Satisfied Charges ₹ 170.00 Cr
as on 21-01-2024
- Revenue -8.21%
(FY 2021)
- Profit -11.06%
(FY 2021)
- Ebitda
- Total Assets -1.08%
(FY 2021)
About Mape Pharmascience Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.00 Cr as per MCA.
- CIN/LLPIN/FCRN
AAG-4828
- Incorporation Date
27 May 2016
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mape Pharmascience Llp?
Designated Partners(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jacob Mathew  | Designated Partner | 27-May-2016 | Current |
| Ramprasad Mathrubutham | Designated Partner | 27-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Mape Pharmascience Llp.
Mape Pharmascience Llp, for the financial year ended 2021, experienced Minor drop in revenue, with a 8.21% decrease. The company also saw a substantial fall in profitability, with a 11.06% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mape Pharmascience Llp?
Unlock access to Mape Pharmascience Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rl Api Private LimitedActive 9 years 8 monthsRamprasad Mathrubutham and Jacob Mathew are mutual person
- Mape Advisory Group Private LimitedActive 23 years 3 days
Ramprasad Mathrubutham and Jacob Mathew are mutual person
- Mape Securities Private LimitedActive 18 years 6 months
Ramprasad Mathrubutham and Jacob Mathew are mutual person
- Mape Consumer Products LlpActive 10 years 17 days
Ramprasad Mathrubutham and Jacob Mathew are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Rbl Bank Limited Creation Date: 22 Feb 2018 | ₹51.00 Cr | Open |
Axis Bank Limited Creation Date: 09 Feb 2018 | ₹82.50 Cr | Open |
Idbi Trusteeship Services Limited Creation Date: 22 Nov 2017 | ₹30.00 Cr | Satisfied |
How Many Employees Work at Mape Pharmascience Llp?
Unlock and access historical data on people associated with Mape Pharmascience Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mape Pharmascience Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mape Pharmascience Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
